Concepedia

Neddie Zadeikis

NZ

Statistics

Publications

9

Citations

515

H-Index

9

Active since

2012

Affiliations

AbbVie (United States)(Current)

Assistance Publique – Hôpitaux de Paris

Université Paris Cité

Centre de Recherche sur l'Inflammation

Hôpital Beaujon

Neddie Zadeikis is an author at AbbVie (United States) specializing in antiviral therapy, antiviral pharmacotherapy, and viral hepatitis treatment.

Publications per year

2012–2019

9

Publications

9

Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis

Tarik Asselah, Kris V. Kowdley, Neddie Zadeikis et al. · Clinical Gastroenterology and Hepatology · 2017 · 230 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

ASP2151 for the Treatment of Genital Herpes: A Randomized, Double-Blind, Placebo- and Valacyclovir-Controlled, Dose-Finding Study

Stephen K. Tyring, Anna Wald, Neddie Zadeikis et al. · The Journal of Infectious Diseases · 2012 · 88 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial

Tarik Asselah, Samuel S. Lee, Betty Yao et al. · The Lancet. Gastroenterology & hepatology · 2018 · 60 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1–6 Hepatitis C Virus Infections and Compensated Liver Disease

Edward Gane, Fred Poordad, Neddie Zadeikis et al. · Clinical Infectious Diseases · 2019 · 37 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older

Graham R. Foster, Tarik Asselah, Sarah Kopecky‐Bromberg et al. · PLoS ONE · 2019 · 36 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 9